PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29642147-1	2018	PURPOSE: Using bibliometrics, we analyzed the research status of immune checkpoint blockade (ICB, a popular tumor immunotherapy method represented by antibodies targeted CTLA-4 and PD-1/PD-L1) in tumor immunotherapy in China during the past 2 decades.	indole-2-carboxylic acid	93-96	programmed cell death 1	Homo sapiens	181-185	
35241815-2	2022	Here we report the design and performance of systemically administered protease activity sensors conjugated to anti-programmed cell death protein 1 (alphaPD1) antibodies for the monitoring of antitumour responses to ICB therapy.	indole-2-carboxylic acid	216-219	programmed cell death 1	Homo sapiens	116-147	
32110280-4	2020	ICB therapy was defined as treatment with any CTLA-4, PD-1, and/or PD-L1 monoclonal antibody.	indole-2-carboxylic acid	0-3	programmed cell death 1	Homo sapiens	54-58